DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas frequency and clinical significance

Pancreas

Volumn 43, Issue 8, 2014, Pages 1264-1270

  Liu, Weiguo ^a   Shia, Jinru ^a   Gönen, Mithat ^a   Lowery, Maeve A ^a   O'Reilly, Eileen M ^a   Klimstra, David S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Immunohistochemistry; Lynch syndrome; Microsatellite instability; Pancreas cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN; CHYMOTRYPSIN; MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; SYNAPTOPHYSIN; TRYPSIN; ADENOSINE TRIPHOSPHATASE; DNA; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SPECIFIC SURVIVAL; DNA MISMATCH REPAIR ABNORMALITY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC DISORDER; GERMLINE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MISMATCH REPAIR; PANCREAS ACINAR CELL CARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; SECOND DEGREE RELATIVE; SURVIVAL RATE; ADOLESCENT; CHILD; ENZYMOLOGY; FAMILIAL CANCER; FAMILY HEALTH; GENETICS; LIVER TUMOR; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ACINAR CELL; CHILD; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA, NEOPLASM; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; GERM-LINE MUTATION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASTIC SYNDROMES, HEREDITARY; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84916599037     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000190     Document Type: Article

References (26)

1. Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol. 2007; 20(SUPPL. 1):S94-S112.
2. Toll AD, Hruban RH, Ali SZ. Acinar cell carcinoma of the pancreas: clinical and cytomorphologic characteristics. Korean J Pathol. 2013; 47: 93-99.
3. Klimstra DS, Heffess CS, Oertel J.E., et al. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol. 1992; 16:815-837.
4. Stelow EB, Shaco-Levy R, Bao F., et al. Pancreatic acinar cell carcinomas with prominent ductal differentiation: mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma. Am J Surg Pathol. 2010; 34:510-518.
5. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. AFIP Atlas of Tumor Pathology. Vol Fourth Series, Fascicle 6. Washington, DC: The American Registry of Pathology; 2007.
6. Ordonez NG. Pancreatic acinar cell carcinoma. Adv Anat Pathol. 2001; 8:144-159.
7. Abraham SC, Wu TT, Hruban R.H., et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol. 2002; 160:953-962.
8. La Rosa S, Adsay V, Albarello L., et al. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers. Am J Surg Pathol. 2012; 36:1782-1795.
9. Abraham SC, Wu TT, Klimstra D.S., et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol. 2001; 159:1619-1627.
10. Sorscher SM. Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report. Eur J Cancer Care (Engl). 2009; 18:318-319.
11. Simon M, Bioulac-Sage P, Trillaud H., et al. FOLFOX regimen in pancreatic acinar cell carcinoma: case report and review of the literature. Acta Oncol. 2012; 51:403-405.
12. Ang C, Herran LA, Lagunes D.R., et al. A case report of a patient with advanced acinar cell carcinoma of the pancreas: long-term survival with regional, systemic and targeted therapy. Tumori. 2013; 99:e61-e64.
13. Pfrommer S, Weber A, Dutkowski P., et al. Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient. Case Rep Oncol. 2013; 6:497-503.
14. Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol. 2002; 20:4673-4678.
15. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010; 138:2073-2087.e2073.
16. Shia J, Holck S, Depetris G., et al. Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry. Fam Cancer. 2013; 12:241-260.
17. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008; 10:293-300.
18. Ribic CM, Sargent DJ, Moore M.J., et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003; 349:247-257.
19. Sargent DJ, Marsoni S, Monges G., et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010; 28:3219-3226.
20. Karamurzin Y, Zeng Z, Stadler Z.K., et al. Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol. 2012; 43:1677-1687.
21. Agaimy A, Kaiser A, Becker K., et al. Pancreatic-type acinar cell carcinoma of the liver: a clinicopathologic study of four patients. Mod Pathol. 2011; 24:1620-1626.
22. Park JG, Vasen HF, Park K.J., et al. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum. 1999; 42:710-715; discussion 715-716
23. Vakiani E, Young RH, Carcangiu M.L., et al. Acinar cell carcinoma of the pancreas metastatic to the ovary: a report of 4 cases. Am J Surg Pathol. 2008; 32:1540-1545.
24. Wisnoski NC, Townsend CM Jr, Nealon WH, et al. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma. Surgery. 2008; 144:141-148.
25. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol. 1993; 143:685-698.
26. Lowery MA, Klimstra DS, Shia J, et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist. 2011; 16:1714-1720.